Anvi Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 52 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.25 Cr
- Satisfied Charges ₹ 9.30 M
- Revenue Growth 15.70%
- Profit Growth 9.15%
- Ebitda 36.40%
- Net Worth 26.32%
- Total Assets -9.24%
About Anvi Lifesciences
Anvi Lifesciences Private Limited (ALPL) was founded in India on 25 October 1972 and has a glorious history of 52 years and three months.Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹1.25 Cr. The company has closed loans amounting to ₹9.30 M, as per Ministry of Corporate Affairs (MCA) records.
Sumit Jagdishprasad, Abha Jagdishprasad, and Divya Sumit serve as directors at the Company.
Company Details
-
Location
Mahesana, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110GJ1972PTC002169
-
Company No.
002169
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Oct 1972
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Anvi Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Jagdishprasad
|
Director | 01-Oct-2002 | Current |
|
Abha Jagdishprasad
|
Director | 05-May-2009 | Current |
|
Divya Sumit
|
Director | 21-Jun-2008 | Current |
Financial Performance of Anvi Lifesciences.
Anvi Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.7% increase. The company also saw a slight improvement in profitability, with a 9.15% increase in profit. The company's net worth Soared by an impressive increase of 26.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anvi Lifesciences?
In 2023, Anvi Lifesciences had a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ishita Drugs And Industries LimitedAbha Jagdishprasad is a mutual person
-
Ishita Overseas Private LimitedSumit Jagdishprasad and Abha Jagdishprasad are mutual person
-
Umang Financial Services Limited
Sumit Jagdishprasad is a mutual person
Charges (Loans)
₹12.50 M
₹9.30 M
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.67 Cr
- Others : 0.58 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2019 | Others | ₹5.80 M | Open |
| 17 Apr 2014 | Corporation Bank | ₹6.70 M | Open |
| 26 Feb 2010 | Corporation Bank | ₹9.30 M | Satisfied |
How Many Employees Work at Anvi Lifesciences?
Unlock and access historical data on people associated with Anvi Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anvi Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anvi Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
